Emergency icon Important Updates

Bradley Marino, MD, MBA

Bradley Marino, MD, MBA
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Title Department Chair of Heart, Vascular & Thoracic and Division Chair of Cardiology and Cardiovascular Medicine
Department Pediatric Cardiology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Both Adults and Children & Adolescents
Languages English
Surgeon No
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Specialties & Treatments

Treatment & Services

  • Department of Pediatric Cardiology and CT Surgery
View all 1 Treatment & Services +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Bradley Marino, MD, MBA

Bradley S. Marino, MD, MPP, MSCE, MBA is the Ronald and Helen Ross Distinguished Chair of Pediatric Cardiology and Chair of the Department of Heart, Vascular, & Thoracic and the Division Chair of Cardiology and Cardiovascular Medicine at Cleveland Clinic Children’s. He also serves on the Cleveland Clinic Children’s Hospital Executive Committee as a Vice-Chief for the Children’s Institute and the Chair of the Children’s Institute Strategic Advisory Council. In addition, he serves as the Executive Co-Director of the Neurodevelopmental Support Program at the Cleveland Clinic Children’s Hospital for Rehabilitation. Prior to joining Cleveland Clinic Children’s, Dr. Marino was a Professor of Pediatrics and Medical Social Sciences at the Northwestern University Feinberg School of Medicine. Dr. Marino was the creator and Director of the Center for Cardiovascular Innovation in the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago (Lurie Children’s) and the NICU-Cardiac Neurodevelopmental Program serving the long-term neurodevelopmental needs of these high-risk pediatric populations. While at Lurie Children’s he served as the Director of the Regenstein Cardiac Care Unit and Director of Inpatient Cardiology. At Northwestern University he served on the steering committee for the Institute for Innovations in Developmental Sciences (DevSci) and as the Co-Director of the DevSci Neurodevelopmental Core. At Northwestern University Feinberg School of Medicine, he served on the Clinical Research Council, and as a member of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute Internal Advisory Committee and the NUCATS Institute KL2 Executive Committee.

Dr. Marino earned his medical degree from Harvard Medical School and a Master’s degree in Public Policy in Health Care Policy from the John F. Kennedy School of Government at Harvard University. He completed his pediatric residency at Johns Hopkins Hospital and a combined fellowship in Pediatric Cardiology and Pediatric Critical Care Medicine at the Children’s Hospital of Philadelphia. While at the Perelman School of Medicine at the University of Pennsylvania, Dr. Marino completed a Master’s of Science degree in Clinical Epidemiology at the Center for Clinical Epidemiology and Biostatistics. He completed a Master’s degree in Business Administration in Healthcare Management at the University of Texas-Dallas Naveen Jindal School of Management. 

Dr. Marino is an internationally recognized pediatric cardiovascular outcomes researcher. Dr. Marino’s research interests have focused on the impact of surgical and intensive care unit factors on mortality and morbidity, as well as the impact of neurodevelopmental, psychosocial, and physical morbidities on quality of life, functional status, and behavioral and emotional outcomes in the high-risk complex congenital heart disease population. He is also pursuing novel investigations on the impact of neurodevelopmental health and cardiovascular health in the young. Dr. Marino’s scientific work has been supported through more than 2 dozen grants as a Principal Investigator or Co-Investigator from the National Institute of Health through NHLBI (RO1, R13, R34, R43, R44 SBIR, K23, UO1), NICHD (U24), the American Heart Association (AHA) (Strategically Focused Research Network for Children), the Children’s Heart Foundation, other national foundations, and internal grants. He has published more than 200 peer-review publications and written or edited more than a dozen books and 75 book chapters on pediatric cardiology, pediatric cardiac intensive care, and general pediatric medicine. He has been invited for 40 Visiting Professorships and given more than 240 international and national lectures based on his scientific inquiry. 

Dr. Marino is an international leader and advocate for children with congenital and acquired heart disease. He has served as the American Heart Association (AHA) Chair of the Young Hearts Council (Council on Lifelong Congenital Heart Disease and Heart Health in the Young), President of the AHA Chicago Metropolitan Board, inaugural Co-Chair for the international Cardiac Neurodevelopmental Outcome Collaborative, and the inaugural Chair of the Medical Advisory Board for Conquering Congenital Heart Disease, He has also served as a member of the American Academy of Pediatrics Section on Cardiology and Cardiac Surgery Executive Committee, Pediatric Cardiac Intensive Care Society Board of Directors, AHA National Council Operations Committee, and Cardiac Networks United Steering Committee. He currently serves as the national Chair for the AHA Council Operations Committee, Co-Chair for the Congenital Heart Public Health Consortium and as a member of the Cleveland AHA Board. Dr. Marino was selected for the highly competitive Association of Medical School Pediatric Department Chairs Pediatric Leadership Development Program and the Cleveland Clinic Leadership Momentum leadership development programs. Dr. Marino is a highly respected educator and was elected to the American Pediatric Society and Feinberg Academy of Medical Educators at the Northwestern University Feinberg School of Medicine and awarded the Heart Institute Peter B. Manning Educational Award at Cincinnati Children’s Hospital Medical Center. Dr. Marino has received multiple national awards including the AHA Meritorious Achievement Award, AHA Extending and Improving People’s Lives Award, Conquering Congenital Heart Disease Heart Hero Award, Cardiac Neurodevelopmental Outcome Collaborative Newburger-Bellinger Award, and Congenital Heart Foundation Congenital Heart Defect Champion Award.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Graduate School - The University of Texas at Dallas Naveen Jindal School of Management
Master of Business Administration - Healthcare Management
Richardson, TX United States

Graduate School - Perelman School of Medicine at the Univeristy of Pennsylvania Center for Clinical Epidemiology and B
Masters of Science in Clinical Epidemiology
Philadelphia, PA United States

Fellowship - The Children's Hospital of Philadelphia
Pediatric Critical Care Medicine
Philadelphia, PA United States

Fellowship - The Children's Hospital of Philadelphia
Pediatric Cardiology
Philadelphia, PA United States

Residency - Johns Hopkins Hospital
Baltimore, MD United States

Medical Education - Harvard Medical School
Boston, MA United States

Graduate School - Harvard University John F. Kennedy School of Government
Masters in Public Policy in Health Care Policy
Cambridge, MA United States

Undergraduate - University of Virginia
Charlottesville, VA


  • Pediatrics - Pediatric Cardiology
  • Pediatrics - Pediatric Critical Care Medicine
  • Pediatrics
Research & Publications

Research & Publications

See publications for Bradley Marino, MD, MBA.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/10/2024, Dr. Marino has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top